Background and Aims: End-stage renal disease patients treated by hemodialysis (HD) are more susceptible for infection by viral hepatitis and human immunodeficiency virus (HIV) infections. Infection by these viruses is promoted by the characteristic immunological dysfunction that develops in renal failure and interferes with the patient's ability to eliminate these viruses. Prevalence of these viruses among hemodialysis patients in Jenin District (Palestine) was not studied until now, we aimed in this study to determine the prevalence of HCV, HBV and HIV among hemodialysis patients in Jenin District using serological methods, and to define the main risk factors for HCV infection. Materials and Methods: End-stage renal disease (ESRD) patients on maintenance hemodialysis from various demographic areas in Jenin District were included in the study. Data such as age, sex, drug abuse, history of transplantation were examined. Serological markers for HCV, HBV and HIV were determined using a microparticle enzyme immunoassay (MEIA). Pearson's correlation factor and independent samples t-test were used to analyze the significance of results. Results: The patients were 77 (42 males, 35 females, mean age 50.73 ± 16.78 years [age range: 14 -80 years]), the mean duration of dialysis was 26.97 months with a standard deviation of 35.19 days. The prevalence of HCV was 24.68 % while the prevalence of HBsAg and HIV were 0% respectively. HCV seropositivity was associated with longer period of dialysis (P=0.000). There was no statistically significant correlation between age and HCV seropositivity (P=0.630), also there was no statistically significant relationship between sex and infection with HCV (P=0.849).
Introduction
emodialysis (HD) patients suffer from many complications of the disease, among these are viral infections.
Hemodialysis patients are at high risk of viral hepatitis due to the high number of blood transfusion sessions, prolonged vascular access and the potential for exposure to infected patients and contaminated equipments (1) . Patients on chronic hemodialysis have a high prevalence of hepatitis C (HCV) infection, which is now recognized as the principal cause of liver disease in kidney failure patients undergoing renal replacement therapy (2) . HCV prevalence in hemodialysis patients varies considerably among different areas of the world (3) . The prevalence of HCV infection among dialysis patients also varies among dialysis centers within a single country (4) . The prevalence of HCV antibodies has been reported to range from 1.9 % to 80 % (1), on the other hand, HBV infection is less prevalent than HCV in hemodialysis units (5) . The rate of serum hepatitis B surface antigen (HBsAg) seropositivity in patients on maintenance hemodialysis in the developed world is currently low (0-10%) but outbreaks of acute HBV infection continue to occur in this setting, on the other hand, the prevalence of HBV infection within dialysis units in developing countries appears higher (2-20%) based on relatively few reports (1) . Compared with rate of infection with HCV or HBV, the risk of infection with HIV among hemodialysis patients is lower as the contact with contaminated sources is low (6) . No previous study has been reported concerning the prevalence of hepatitis viruses or HIV infection among hemodialysis patients in Jenin District (Palestine). So we aimed in this study to estimate the prevalence of HBV, HCV, and HIV among hemodialysis patients in Jenin District using serological techniques and to determine the main risk factors for HCV infection.
Methods
Area of study This study included Jenin District which includes Jenin city and the surrounding villages with a population of about 280000. 
Patients

Setting of the study
The study has been conducted at the laboratory and the kidney unit of The Martyr Dr. Khalil Sulaiman Hospital in Jenin city which is the only hemodialysis unit in Jenin district where all patients from Jenin district are treated.
Serological tests
For anti-HCV antibodies determination, IMx HCV version 3.0 kit (Abbott IMx System, Abbott Laboratories, and Abbott Park, Illinois, USA) was used. This is a microparticle enzyme immunoassay (MEIA) for the detection of antibodies to hepatitis C virus (anti -HCV) in human serum or plasma. For HBsAg determination, IMx HBsAg version 2.0 kit (Abbott IMx System) was used. This is a qualitative third generation microparticle enzyme immunoassay for the detection of hepatitis B surface antigen (HBsAg) in human serum or plasma. For HIV determination, IMx HIV-1/HIV-2 III Plus kit (Abbott IMx System, Abbott Laboratories, Abbott Park, Illinois, USA) was used. This is a microparticle enzyme immunoassay (MEIA) for the qualitative detection of antibodies to human immunodeficiency viruses type 1 and/or type 2 (HIV-1/HIV-2) in human serum or plasma.
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Statistical analysis was performed using the Statistical Package for Social Sciences (SPSS) version 10 (SPSS Inc., Chicago, IL, USA). Pearson's correlation factor was used to test if there is a relation between duration of dialysis or age and infection with hepatitis C virus (HCV). Independent samples T-test was used to test if there was differences in infection with HCV between patients on hemodialysis for ≥ 3 years and those on hemodialysis for < 3 years. T-test was also used to test if there was a relationship between sex and HCV seropositivity. All tests were two sided, P values < 0.05 were considered as significant.
Results
Age interval (years )
Number of patients The mean duration of dialysis was 26.97 months with a standard deviation of 35.19 months, the minimum dialysis period was 1/2 month and the maximum dialysis period was 180 months. The study showed that 68.8 % of patients were between age 16 and 60 years old, the age intervals of patients are shown in table (1) . In this study, 19 patients (24.68 %) were anti-HCV positive [10 were males (52.6 %) and 9 were females (47.4%)], on the other hand, there was no patient positive for HBsAg or HIV. Considering the patients infected by HCV, there was not any patient with former drug abuse or had a history of tattooing. None of the patients with a history of transplantation were positive for anti-HCV during the study period. The study showed that there was a strong significant correlation between duration of dialysis and infection with HCV (Pearson's correlation coefficient= 0.584; P-value= 0.000).The mean duration for HCV positive patients was 62.63 months while for HCV negative patients, it was 14.76. The study showed that the prevalence of anti-HCV among patients with dialysis interval (< 3 years) was 7.55 % (4 patients out of 53); on the other hand, the prevalence of anti-HCV among patients with dialysis interval (≥ 3 years) was 62.5 % (15 patients out of 24). HCV infection seems to be significantly higher in patients on hemodialysis for ≥ 3 years compared to patients on hemodialysis for < 3 years (Pvalue=0.000).
The results showed that there was no significant correlation between age and infection with HCV (Pearson's correlation coefficient = -0.056; P = 0.630).
The results also showed that there was no statistically significant relationship between sex and infection with HCV (P-value = 0.849)
Discussion
The prevalence of HCV among dialysis patients in Jenin District is higher than that found in Nigeria (6), USA (7, 8) , Japan (9) (36) where they found that HCV seropositivity was associated with age. The results showed that there was no statistically significant relationship between sex of patients and infection with HCV, this is in line with what was found in Syria (43), Egypt (44) but this is not in line with that found in Iraq (3) and USA (8) where they found that HCV seropositivity was associated with female gender and male gender respectively. The present study showed that duration of dialysis is an important risk factor for infection by HCV among hemodialysis patients in Jenin District, this is in line with what was found in Iraq (3), USA (8) (44) . The results also showed that HCV infection is significantly higher in patients on hemodialysis for ≥ 3 years compared to patients on hemodialysis for < 3 years, this is in line with a previous study in Syria (43) . It is obvious from the results that duration of dialysis is a very important risk factor for HCV infection. The effect of duration of dialysis on HCV infection may be mainly due to nosocomial transmission of HCV in the dialysis unit as indicated by other studies which have shown the role of HD environment (especially infected patients) for dissemination of HCV among patients (52) (53) . The number of staff per patients has an important role in the dissemination of HCV infection. A previous study showed that the combination of understaffing and a high level of infected patients in the dialysis unit increase the risk for HCV nosocomial transmission (54) . From our observations in this study, it was not unusual to find the dialyzing staff taking care of susceptible and infected patients in the same shift. In addition, the dialyzing staff-in many times -did not change the gloves during transferring from patient to patient even during transferring from HCV positive to HCV negative patients, without taking care that this practice may facilitate the dissemination of HCV infection from one patient to another. In our opinion it seems that the main source of infection by hepatitis c virus (HCV) is nosocomial during the dialysis process as a result of contact with contaminated equipments and persons. This transmission of HCV to dialysis patients in Jenin district might be as a result of contact among patients, between patients and dialysis machines or equipments, and between patients and dialysis staff especially that there was no isolation of HCV positive patients on special dialysis units or machines.
Conclusion
The prevalence of HBsAg and HIV among hemodialysis patients in Jenin District was 0% respectively on the other hand, the prevalence of HCV was 24.68%. The prevalence of HCV among hemodialysis patients in Jenin District is considered high compared to many developed and developing countries around the world including many Arab countries. This is mainly due to nosocomial transmission in the dialysis unit. Universal infection control precautions are very important for prevention of nosocomial HCV transmission in our hemodialysis unit. These may include isolation of HCV positive patients in a special unit or at least special section in the dialysis unit with a special dialysis staff; disinfecting all dialysis unit surfaces especially monitors hardly after each patient treatment; disinfecting hands and changing gloves and gowns between patient contacts; preparing medications outside the dialysis unit; using of items, medications, or instruments that are dedicated for use only for one patient. Dialysis staff must also review their practices and increase their vigilance in order to decrease HCV transmission. Palestinian Ministry of Health should be aware about the prevalence of HCV infection among hemodialysis patients generally and in Jenin District in particular in order to make necessary changes in the infection control measures. Implementations of surveillance systems and educational programs for the hemodialysis unit's personnel about recommended infection control measures in the hemodialysis units are necessary. Implementation of a hard and effective infection control measures may cause a decrease in the incidence and prevalence of HCV infection among hemodialysis patients in Jenin district.
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